Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

Abstract Objectives Glioblastoma is a highly aggressive and fatal brain malignancy, and effective targeted therapies are required. The combination of standard treatments including surgery, chemotherapy and radiotherapy is not curative. Chimeric antigen receptor (CAR) T cells are known to cross the b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-01-01
coleção:	Clinical & Translational Immunology
Assuntos:	CAR T cells chimeric antigen receptor EGFRvIII glioblastoma immunotherapy
Acesso em linha:	https://doi.org/10.1002/cti2.1440
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!